<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/abc" -->
<rss version="0.92">
<channel>
	<title>ZAMP Bionews</title>
	<link>http://bionews.zampbioworld.org</link>
	<description></description>
	<lastBuildDate>Sat, 13 Feb 2010 13:37:12 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Helix BioPharma Announces Positive Interim Results From Its Ongoing Phase II Pharmacokinetic Clinical Study Of Topical Interferon Alpha-2b</title>
		<description><![CDATA[Helix BioPharma Corp. (TSX, FSE: HBP; Pink Sheets: HXBPF) announced that  the first ten patients that have been enrolled in its Phase II  pharmacokinetic study of Topical Interferon Alpha-2b in patients with  low-grade cervical lesions have completed the pharmacokinetic primary  endpoint analyses with positive findings.
All ten of these patients, at all [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34689</link>
			</item>
	<item>
		<title>Allegheny General Hospital Study Demonstrates Safety And Potential Efficacy Of Oral Allergy Treatment</title>
		<description><![CDATA[An oral allergy treatment administered in drops under the tongue is a  safe and effective alternative to injections for adults who are allergic  to ragweed pollen, according to a study published  in the Journal of  Allergy and Clinical Immunology by allergic disease specialist at  Allegheny General Hospital.
Widely used in Europe, [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34688</link>
			</item>
	<item>
		<title>Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine</title>
		<description><![CDATA[Circassia Ltd, a specialty biopharmaceutical company focused on allergy,  announced that its ToleroMune(R) ragweed allergy T-cell vaccine  achieved positive results in a recently completed phase II clinical  trial. Ragweed allergy is particularly common in America, where it  affects approximately 25% of the population. Circassia&#8217;s latest clinical  results follow two earlier [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34687</link>
			</item>
	<item>
		<title>FDA Approves Benicar(R) For The Treatment Of High Blood Pressure In Children And Adolescents Aged 6-16</title>
		<description><![CDATA[Daiichi Sankyo, Inc. announced that the U.S. Food and Drug  Administration (FDA) has approved the hypertension treatment Benicar®  (olmesartan medoxomil) for use in children and adolescents 6 to 16 years  of age.(1)  Benicar was originally approved in 2002 for the treatment  of hypertension in adults.
Approximately 5 percent or 3.6 million [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34686</link>
			</item>
	<item>
		<title>Data Monitoring Committee Recommends Continuation Of Phase III Study Of StemEx(R), A Cord Blood Stem Cell Product, For Leukemia And Lymphoma</title>
		<description><![CDATA[The Gamida Cell-Teva Joint Venture (JV) announced that the Data  Monitoring Committee (DMC) has independently reviewed preliminary data  from the pivotal registration, Phase III clinical trial of StemEx  (called ExCell) and has recommended that the JV continue to enroll  patients in this study. The next data analysis is anticipated to take [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34685</link>
			</item>
	<item>
		<title>Obesity And Diabetes Study Weighs Influence Of Genetics, Lifestyle</title>
		<description><![CDATA[A team of Northern Arizona University-led researchers is using nearly  $1.3 million in new funding from the National Institutes of Health to  continue with the world&#8217;s longest-running study on obesity and Type 2 diabetes.
Obesity and diabetes have been described as the major public health  concerns of the 21st century, explains Leslie Schulz, [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34684</link>
			</item>
	<item>
		<title>Researchers Find Air Pollution Linked To Progression Of Atherosclerosis</title>
		<description><![CDATA[Researchers at the Keck School of Medicine of the University of Southern  California (USC), in collaboration with international partners in Spain  and Switzerland and colleagues in California, have found that exposure  to air pollution accelerates the thickening of artery walls that leads  to cardiovascular disease.
The study, published this week in the [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34683</link>
			</item>
	<item>
		<title>Heartache To Heartbreak &#8212; How To Recognize A Heart Attack, Or Avoid One All Together</title>
		<description><![CDATA[Not everyone who suffers a heart attack clutches their chest and falls to the floor. &#8220;I woke up and felt like a  pill was stuck in my throat,&#8221; says Betsy, a 68-year-old patient from  Upper Providence. &#8220;I was taking antibiotics at the time  and really didn&#8217;t think much of it,&#8221; she adds. [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34682</link>
			</item>
	<item>
		<title>Hospital For Special Surgery Launches Quality Research Center</title>
		<description><![CDATA[Patients with orthopedic and autoimmune conditions expect Hospital for  Special Surgery (HSS)&#8211;because of its leadership role&#8211;to deliver the  highest quality care. To further accomplish this mission, HSS is  announcing the creation of a Quality Research Center with an innovative  structure for applying research methodologies to health-care quality  issues.
Physicians, nurses and [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34681</link>
			</item>
	<item>
		<title>Quitting Smoking Especially Difficult For Select Groups</title>
		<description><![CDATA[With the national trend toward quitting smoking flat, psychologists are  finding some success with treatments aimed at helping smokers from  underserved groups, including racial and ethnic minorities and those  with psychiatric disorders.
In a special section of this month&#8217;s issue of the Journal of  Consulting and Clinical Psychology, published by the American [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34680</link>
			</item>
	<item>
		<title>Strengthen Your Core Like Olympic Skiers</title>
		<description><![CDATA[If you&#8217;re going to hurl yourself down a mountain at speeds in excess of  70 miles per hour you&#8217;d better have a strong core. That&#8217;s why Olympians  like Ted Ligety, Lindsey Vonn and Sara Schleper work on developing  strong &#8220;core&#8221; muscles all season long.
Most people know that having a strong core is [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34679</link>
			</item>
	<item>
		<title>A Healthy Relationship Depends On Your Patterns Of Love</title>
		<description><![CDATA[Do you make the same mistakes in love over and over again? For example,  do you always seem to pick the wrong partner or always experience the  same negative romantic outcome? If so, you need to understand your  developmental history of love and break the pattern, according to Dr.  Mark Beitel, [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34678</link>
			</item>
	<item>
		<title>Cartilage Replacement Using The Body&#8217;s Own Cells: Fast, Affordable And A Perfect Fit</title>
		<description><![CDATA[Injuries to joints and cartilage can have serious consequences,  including osteoarthritis. Cartilage degeneration in joints is a  widespread disease in Germany and worldwide. Prof. Dr. Prasad Shastri is  an expert in tissue engineering (TE), tissue construction and tissue  cultivation using the body&#8217;s own cells. He is Professor of Biofunctional  Macromolecular [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34677</link>
			</item>
	<item>
		<title>Technology And Culture Determine Our View Of The Brain</title>
		<description><![CDATA[What does the brain look like? What do we really know about our brains?  For centuries, we&#8217;ve been telling ourselves time and again that we now  have an objective view of our brains. However, objectivity depends on  technological developments, human actions and social and cultural  factors, to name but a few. [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34676</link>
			</item>
	<item>
		<title>Low Levels Of Natural Antibodies Behind Stroke</title>
		<description><![CDATA[The chances of suffering a stroke are linked to the presence of  a certain type of antibody in the immune system, a new study from  Karolinska Institutet shows. The researchers hope to be able to develop a  vaccine that can mobilise the body&#8217;s own defence against  arteriosclerosis and stroke.
The research group, [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34675</link>
			</item>
	<item>
		<title>Rye More Filling Than Wheat</title>
		<description><![CDATA[Wholegrain bread is good and good for you, as most people know. But it  is not only the fiber-rich bran, the outer shell of the grain, that is  healthful. On the contrary, research at the Lund University Faculty of  Engineering shows that bread baked with white rye flour, which is flour  [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34674</link>
			</item>
	<item>
		<title>Baked Rhubarb Could Help Fight Cancer</title>
		<description><![CDATA[Eating rhubarb baked in a crumble is not only tasty it may also be the  best way to take advantage of its health benefits, and could lead to the  development of new cancer treatments.
Researchers have found that baking British garden rhubarb for 20 minutes  dramatically increases its levels of anti-cancerous chemicals. The [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34673</link>
			</item>
	<item>
		<title>Blood Clotting Finding May Lead To New Treatments</title>
		<description><![CDATA[A key protein that causes the blood to clot is produced by blood vessels  in the lungs and not just the liver, according to new research  published in the journal PLoS One, led by scientists at Imperial College  London.
The findings may ultimately help scientists to develop better treatments  for conditions where [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34672</link>
			</item>
	<item>
		<title>Novartis Gains Exclusive Rights To Debio 025, An Antiviral Agent In Phase IIb Development As Potential First-in-class Hepatitis C Therapy</title>
		<description><![CDATA[Novartis has gained exclusive rights to develop and market Debio 025  (alisporivir), a potential first-in-class antiviral agent currently in  Phase IIb development for the treatment of hepatitis C. Debio  025 is the first in a new class of drugs called cyclophilin inhibitors  which could become part of the future standard of [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34671</link>
			</item>
	<item>
		<title>The Genetic Secrets To Jumping The Species Barrier</title>
		<description><![CDATA[Scientists have pinpointed specific mutations that allow a common plant  virus to infect new species, according to research published in the  March issue of the Journal of General Virology. Understanding the  genetics of the key interactions between viruses and hosts could  provide insight to how some viruses manage to jump the [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34670</link>
			</item>
	<item>
		<title>Antibiotics As Active Mutagens In The Emergence Of Multidrug Resistance</title>
		<description><![CDATA[Multidrug resistant bacteria such as Methicillin-resistant Staphylococcus  aureus (MRSA) pose a  major problem for patients, doctors, and the pharmaceutical industry. To  combat such bacteria, it is critical to understand how resistance is  developed in the first place. It is commonly thought that an incomplete  course of antibiotics would lead to [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34669</link>
			</item>
	<item>
		<title>Study Finds That Lower Medicare Fees Do Not Increase Volume Of Patient Care</title>
		<description><![CDATA[Do physicians provide more services to Medicare patients to make up  for lower Medicare fees? With almost 42 million people enrolled in  Medicare in the United States in 2008, it&#8217;s a question that could have a  very costly answer.
Jack Hadley, professor and senior health services researcher in George  Mason University&#8217;s College [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34668</link>
			</item>
	<item>
		<title>First FDA-Approved Stem Cell Trial In Pediatric Cerebral Palsy</title>
		<description><![CDATA[Medical College of Georgia researchers are conducting the first  FDA-approved clinical trial to determine whether an infusion of stem cells from umbilical cord blood  can improve the quality of life for children with cerebral palsy.
The study will include 40 children age 2-12 whose parents have stored  cord blood at the Cord Blood [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34667</link>
			</item>
	<item>
		<title>Animal Models That Help Translate Regenerative Therapies From Bench To Bedside</title>
		<description><![CDATA[Clinical testing and development of novel therapies based on advances in  tissue engineering and regenerative medicine that will one day enable  the repair and replacement of diseased or damaged human muscle, bone,  tendons, and ligaments depends on the availability of good animal  models. The highlights of a recent workshop that explored [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34666</link>
			</item>
	<item>
		<title>In Fight Against Obesity, Tiny Fruit Fly Could Offer Big Clues</title>
		<description><![CDATA[The tiny tongue of a fruit fly could provide big answers to questions  about human eating habits, possibly even leading to new ways to treat obesity, according to a study from a team  of Texas A&#38;M University researchers.
Paul Hardin, who holds the rank of Distinguished Professor of Biology,  along with colleagues Abhishek [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34665</link>
			</item>
	<item>
		<title>High-Intensity End-Of-Life Approaches Confer Survival Benefit</title>
		<description><![CDATA[Patients admitted to hospitals with higher-intensity end-of-life care  live longer than those admitted to hospitals with low-intensity  approaches, according to a University of Pittsburgh study available  online and published in the February issue of the journal Medical  Care. Higher-intensity care refers to greater use of life-sustaining  measures such as ICU [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34664</link>
			</item>
	<item>
		<title>Better Knowledge Of Cell Structure Could Aid Organ Reconstruction, Energy Harvesting, More</title>
		<description><![CDATA[Cornel Sultan, assistant professor of aerospace and ocean engineering at  Virginia Tech, is the latest faculty member at the university to learn  he has received a National Science Foundation (NSF) Faculty Early Career  Development (CAREER) award.
Sultan joins a phenomenal list of more than 70 Virginia Tech CAREER  award winners, of which [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34663</link>
			</item>
	<item>
		<title>New Book Suggests Workplace Gendered Tradeoffs Lead To Economic Inequalities For Women</title>
		<description><![CDATA[Despite big changes over recent decades, workplace gender inequalities  endure in the United States and other industrialized nations around the  world. These inequalities are created by facets of national social  policy that either ease or concentrate the demands of care giving within  households and shape expectations in the workplace, according to [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34662</link>
			</item>
	<item>
		<title>Biological Imperfection And Intelligent Design Discussed In New Book</title>
		<description><![CDATA[Humanity&#8217;s physical design flaws have long been apparent &#8211; we have a  blind spot in our vision, for instance, and insufficient room for wisdom  teeth &#8211; but do the imperfections extend to the genetic level?
In his new book, Inside the Human Genome, John Avise examines why &#8211; from  the perspectives of biochemistry [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34661</link>
			</item>
	<item>
		<title>Hospitalist Recruitment And Retention: Building A Hospital Medicine Program</title>
		<description><![CDATA[Recruitment and retention of physicians in all specialties is a national  challenge, and it is expected to become even more difficult due to an  impending physician shortage. As relative newcomers to the long line of  medical specialists, hospitalists pose special challenges. What will  convince a hospitalist to join one organization over [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34660</link>
			</item>
	<item>
		<title>8 Principles Address CT And Radiation Therapy</title>
		<description><![CDATA[The Medical Imaging &#38; Technology Alliance (MITA), the leading  association representing the manufacturers, innovators and developers of  medical imaging and radiation therapy systems, has endorsed eight key  principles to reduce exposure to unnecessary medical radiation, further  minimize medical errors and improve reporting of adverse events.
&#8220;Over the past twenty years innovations by [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34659</link>
			</item>
	<item>
		<title>Tackling Transport And Environment In Africa</title>
		<description><![CDATA[Researchers at the University of York are leading an international  effort to tackle problems such as traffic congestion, air pollution and  road safety in Africa.
They are coordinating an international drive to strengthen scientific  and technological support to enable the implementation of sustainable  transport policies in Sub-Saharan Africa.
The Transport and Environment &#8211; [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34658</link>
			</item>
	<item>
		<title>Human Use Heel First Gait Because It Is Efficient For Walking</title>
		<description><![CDATA[Most running mammals totter along on their toes. In fact, toe running is  far more efficient than landing heel first like humans. Yet when it  comes to long distance endurance running, humans are some of the  best-adapted animals for clocking up the miles, all be it inefficiently.  So, why have we [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34657</link>
			</item>
	<item>
		<title>Keeping Tumor Growth Switched Off: New Drug Created By Researchers</title>
		<description><![CDATA[A novel &#8211; and rapid &#8211; anti-cancer drug development strategy has resulted  in a new drug that stops kidney and pancreatic tumors from growing in  mice. Researchers at the Moores Cancer Center at the University of  California, San Diego, have found a drug that binds to a molecular  &#8220;switch&#8221; found in [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34656</link>
			</item>
	<item>
		<title>Compound Shows Promise Against Intractable Heart Failure</title>
		<description><![CDATA[A chemical compound found normally in the blood has shown promise in  treating and preventing an intractable form of heart failure in a  mouse model of the disease, report researchers at the University of  Illinois at Chicago College of Medicine.
The study is published in the February issue of Circulation.
More than five and [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34655</link>
			</item>
	<item>
		<title>Universal DNA Reader Developed By ASU Scientists To Advance Faster, Cheaper Sequencing Efforts</title>
		<description><![CDATA[Arizona State University scientists have come up with a new twist in  their efforts to develop a faster and cheaper way to read the DNA  genetic code. They have developed the first, versatile DNA reader that  can discriminate between DNA&#8217;s four core chemical components &#8211; ithe key  to unlocking the vital [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34654</link>
			</item>
	<item>
		<title>Linking Breast Cancer Patients With Alternative Therapies</title>
		<description><![CDATA[Biological-based therapies such as diet supplements and vitamins are the  most popular complementary and alternative medicines for women  recovering from breast cancer, according to a Michigan State  University researcher working to create a support intervention for women  in treatment for the disease.
Gwen Wyatt of MSU&#8217;s College of Nursing, in research published [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34653</link>
			</item>
	<item>
		<title>Virtual Reality And Other Technologies Offer Hope For PTSD</title>
		<description><![CDATA[Posttraumatic stress disorder (PTSD) threatens to overload  healthcare and social support systems worldwide as the number of cases  rises and existing treatments are not sufficiently effective. New  approaches to treatment are relying on technology, such as virtual  reality, to alleviate the psychologically damaging effects of PTSD, and  these innovative solutions [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34652</link>
			</item>
	<item>
		<title>Behavioral Therapy Improves Sleep And Lives Of Patients With Pain</title>
		<description><![CDATA[Cognitive behavioral therapy for insomnia significantly improved  sleep for patients with chronic neck or back pain and also reduced the  extent to which pain interfered with their daily functioning, according  to a study by University of Rochester Medical Center researchers.
The study, published online by the journal Sleep Medicine,  demonstrates that a [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/02/13/34651</link>
			</item>
	<item>
		<title>Poniard Pharmaceuticals Announces Phase 2 Trial Of Picoplatin In Metastatic Colorectal Cancer Meets Primary Endpoint And Study Objectives</title>
		<description><![CDATA[Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced final data from a randomized, controlled Phase 2 trial of picoplatin in metastatic colorectal cancer (CRC) patients. The study met its primary objective, as picoplatin in combination with 5-fluorouracil and leucovorin (FOLPI regimen) was associated with a statistically significant reduction in [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/01/26/34650</link>
			</item>
	<item>
		<title>FDA Approves First Percutaneous Heart Valve</title>
		<description><![CDATA[The U.S. Food and Drug Administration approved the Medtronic Melody Transcatheter Pulmonary Valve and Ensemble Delivery System, the first heart valve to be implanted through a catheter, or tube, in a leg vein and guided up to the heart. This new approach to the treatment of adults and children with previously implanted, poorly functioning pulmonary [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/01/26/34649</link>
			</item>
	<item>
		<title>Lupin Receives US FDA Tentative Approval For Memantine HCl Tablets</title>
		<description><![CDATA[Lupin Pharmaceuticals, Inc. (LPI) announced that it has received tentative approval from the US Food and Drug Administration (US FDA) for its Memantine Hydrochloride tablets, 5mg and 10mg.
Lupin&#8217;s Memantine HCl tablets are AB-rated to Namenda® tablets indicated for the treatment of moderate to severe dementia of the Alzheimer&#8217;s type. Namenda had annual sales of approximately [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/01/26/34648</link>
			</item>
	<item>
		<title>Vaccine Approach Extends Life Of Metastatic Prostate Cancer Patients</title>
		<description><![CDATA[In a newly published clinical trial, patients with metastatic prostate cancer who received a vaccine of harmless poxviruses engineered to spur an immune system attack on prostate tumor cells lived substantially longer than patients who received a placebo vaccine, report researchers at Dana-Farber Cancer Institute and affiliated organizations. The findings will be published by the [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/01/26/34647</link>
			</item>
	<item>
		<title>AAN Guideline Evaluates Treatments For Kids With Cerebral Palsy</title>
		<description><![CDATA[A new guideline from the American Academy of Neurology and the Child Neurology Society finds botulinum toxin type A to be an effective treatment for spasticity, muscle tightness that interferes with movement, in children and adolescents with cerebral palsy, but poses some risk. The guideline is published in the January 26, 2010, issue of Neurology®, [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/01/26/34646</link>
			</item>
	<item>
		<title>Rush University Medical Center Leads Nationwide Clinical Trial Of Nutritional Drink For Alzheimer&#8217;s</title>
		<description><![CDATA[Rush University Medical Center is leading a nationwide clinical trial of a nutritional drink to determine whether it can improve cognitive performance in people with mild to moderate Alzheimer&#8217;s.
The study follows recently released results from an earlier trial conducted in Europe showing that the drink, called Souvenaid, improved verbal recall in people with mild disease [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/01/26/34645</link>
			</item>
	<item>
		<title>New Therapeutic Approach Identified For Kidney Disease Associated With Lupus</title>
		<description><![CDATA[Investigators have identified a new disease mechanism and therapeutic approach for a type of advanced kidney disease that is a common cause of complications in patients with lupus. The study was led by investigators at Hospital for Special Surgery and appears in the January 25 online Early Edition of the Proceedings of the National Academy [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/01/26/34644</link>
			</item>
	<item>
		<title>Genome Sequencing Study Finds Clues To Unraveling The Causes Of Deadly Epidemics</title>
		<description><![CDATA[A team of collaborating scientists at The Methodist Hospital Research Institute in Houston, the Broad Institute in Boston, Mount Sinai Hospital in Toronto, and the Ontario Agency for Health Protection and Promotion (OAHPP) have sequenced almost 100 full genomes from three successive epidemics of flesh-eating bacteria. This has resulted in the first precise explanation of [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/01/26/34643</link>
			</item>
	<item>
		<title>Beyond The Ice: Technique For Preserving Pre-Transplant Livers Promises To Improve Patient Outcomes And Expand The Organ Pool</title>
		<description><![CDATA[Preserving organs on ice prior to transplantation, an approach known as cold storage or CS, has been the standard practice in liver transplant for 20 years. Now there is new evidence that a technique called hypothermic machine perfusion (HMP) may offer an improvement, according to the first-ever study comparing the impact of the two techniques [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/01/26/34642</link>
			</item>
	<item>
		<title>ASCP Foundation Awarded Grant For Medication Optimization Study Using Monitor-RX</title>
		<description><![CDATA[The American Society of Consultant Pharmacists (ASCP) Foundation has been awarded a grant in the amount of $93,465 from the Center for Technology and Aging for a research project utilizing Monitor-Rx to optimize the medication regimens of older adults. The ASCP Foundation was selected as one of five grant recipients out of 47 applicants to [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/01/25/34641</link>
			</item>
	<item>
		<title>Elan Drug Technologies Welcomes The NDA Approval Of MS Drug AMPYRA™ (Dalfampridine) Extended Release Tablets</title>
		<description><![CDATA[Elan Drug Technologies, a business unit of Elan Corporation, plc (NYSE: ELN) today issued the following statement regarding the U.S. Food and Drug Administration (FDA) approval of AMPYRA™ (dalfampridine) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA™ will be marketed in [...]]]></description>
		<link>http://bionews.zampbioworld.org/2010/01/25/34640</link>
			</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 3.670 seconds -->
<!-- Cached page served by WP-Cache -->
